University of Miami Sylvester Comprehensive Cancer Center
IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of Resistance in R/R AML? What Are the Strategies to Combine IDH Inhibitors With SoC?
Login to view comments.
Click here to Login
